S100A9 and neoplasm: Previous studies have shown that S100A9 acts as a chemotactic molecule to recruit inflammatory cells or immunocytes, such as MDSCs and neutrophils [27, 28], to the tumor microenvironment, resulting in a proinflammatory microenvironment that promotes tumor progression [29, 30].